The working stroke upon myosin-nucleotide complexes binding to actin.
Journal: 2003/July - Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
Abstract:
For many years, it has been known that myosin binds to actin tightly, but it had not been possible to devise a muscle fiber experiment to determine whether this binding energy is directly coupled to the working stroke of the actomyosin crossbridge cycle. Addressing the question at the single-molecule level with optical tweezers allows the problem to be resolved. We have compared the working stroke on the binding of four myosin complexes (myosin, myosin-ADP, myosin-pyrophosphate, and myosin-adenyl-5'yl imidodiphosphate) with that observed while hydrolyzing ATP. None of the four was observed to give a working stroke significantly different from zero. A working stroke (5.4 nm) was observed only with ATP, which indicates that the other states bind to actin in a rigor-like conformation and that myosin products (M.ADP.Pi), the state that binds to actin during ATPase activity, binds in a different, prestroke conformation. We conclude that myosin, while dissociated from actin, must be able to take up at least two mechanical conformations and show that our results are consistent with these conformations corresponding to the two states characterized at high resolution, which are commonly referred to in terms of having open and closed nucleotide binding pockets.
Relations:
Content
Citations
(12)
References
(29)
Drugs
(1)
Chemicals
(2)
Organisms
(2)
Processes
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Proc Natl Acad Sci U S A 100(11): 6434-6439

The working stroke upon myosin–nucleotide complexes binding to actin

Randall Centre, King's College, London SE1 1UL, United Kingdom
To whom correspondence should be addressed. E-mail: ku.ca.lck@peels.nhoj.
Communicated by Edwin W. Taylor, University of Chicago, Chicago, IL, April 4, 2003
Communicated by Edwin W. Taylor, University of Chicago, Chicago, IL, April 4, 2003
Received 2002 Oct 6

Abstract

For many years, it has been known that myosin binds to actin tightly, but it had not been possible to devise a muscle fiber experiment to determine whether this binding energy is directly coupled to the working stroke of the actomyosin crossbridge cycle. Addressing the question at the single-molecule level with optical tweezers allows the problem to be resolved. We have compared the working stroke on the binding of four myosin complexes (myosin, myosin-ADP, myosin-pyrophosphate, and myosin-adenyl-5′yl imidodiphosphate) with that observed while hydrolyzing ATP. None of the four was observed to give a working stroke significantly different from zero. A working stroke (5.4 nm) was observed only with ATP, which indicates that the other states bind to actin in a rigor-like conformation and that myosin products (M.ADP.Pi), the state that binds to actin during ATPase activity, binds in a different, prestroke conformation. We conclude that myosin, while dissociated from actin, must be able to take up at least two mechanical conformations and show that our results are consistent with these conformations corresponding to the two states characterized at high resolution, which are commonly referred to in terms of having open and closed nucleotide binding pockets.

Abstract

Evidence from electron micrographs for different conformations of myosin led to the rowing model of actomyosin (AM) crossbridge action (1, 2) in which myosin binds to actin in one conformation, undergoes a working stroke, and detaches in a second conformation. The Lymn–Taylor scheme (3) describing the biochemical kinetics of AM provided a natural match to the mechanical model (Fig. 1). The detached myosin products (M.ADP.Pi) state bound to actin, and the working stroke occurred in association with product release. The binding of ATP facilitated dissociation of actin, and its hydrolysis took place while myosin was dissociated. The model postulated that the hydrolysis step is associated with repriming the head from the postpower-stroke structure back to the prepower-stroke form, although there was no evidence on this point at the time. Based on the observation that the detached states, myosin-ATP and M.ADP.Pi, behaved in a similar manner with respect to actin binding, Eisenberg and collaborators (4) favored a model in which there was a single detached conformation of myosin.

An external file that holds a picture, illustration, etc.
Object name is pq1231998001.jpg

The Lymn–Taylor alignment of biochemical states with the crossbridge cycle. Pr = Products, ADP.P.

Measurement of the ATP binding constant (5) and the actin binding constant (6) were crucial steps in allowing the basic energetics of the AM mechanism to be elucidated. Much of the free energy of ATP hydrolysis is associated with actin binding to the M.ADP.Pi state and forming the rigor AM state (7), the part of the scheme that must encompass the working stroke. The myosin state in the absence of nucleotide binds even more tightly to actin, and if it is the energy of AM binding that powers the mechanical action, it would suggest that a working stroke would also result from myosin binding to actin. This idea is consistent with the views of Eisenberg (4) and the “3G” model of contraction (8). In the latter model all myosin states exist in a single myosin conformation and actin binding occurs in two steps, the first being the binding and formation of a weakly bound complex (A state) and the second being the conversion to a tightly bound complex (R state). It was natural to assume that the weak-to-strong (or A-to-R) transition corresponded to the working stroke.

In recent years, a scheme, closely related to that of Lymn and Taylor (3), has been developed based on the crystal structures of myosin subfragment 1 (S1). When crystallized in a variety of nucleotide states, two forms are common, which differ in a number of regions, including the nucleotide binding pocket, the switch 2 region, and the cleft between the upper and lower 50-kDa domains. The two forms generally are labeled based on the state of the nucleotide binding pocket as closed and open. The transition from the closed to the open form appears to be linked with movement of the lever arm and has been associated with the working stroke. The transition from open to closed occurs before the hydrolysis step and has been associated with repriming (9).

These models can be tested directly at the level of a single myosin molecule by using optical tweezers to hold an actin filament taut between two trapped beads and presenting it to a myosin molecule on a third fixed bead (10). Displacements of the actin beads “dumbbell” are monitored and used to detect attachment events; the difference between the mean displacements in free and bound periods gives the myosin working stroke, which under conditions of ATP turnover is ≈5–6 nm. To isolate the working stroke event in the biochemical cycle, we have investigated the binding of myosin and myosin–nucleotide complexes in the absence of ATP, where transitions are restricted to actin binding and loss of nucleotide. Although these transitions are reversible and no net work can be extracted from the dumbbell, any associated working stroke would still be detected as described in Materials and Methods. It is important to emphasize that the observed working stroke reflects the difference in orientations between the bound state and the dissociated state at the moment of attachment. If there is a mixture of different dissociated conformations, the relative rates of actin binding become important.

For each nucleotide, data from a single dumbbell are summarized to avoid combining working strokes from actin filaments of possibly different polarities. Errors are SEM. * indicates pooled data sets (absolute values of the working stroke averaged) using different dumbbells of unknown polarity (except for the case of ATP). BDTC-RLC S1 was used throughout. NA, not applicable.

Acknowledgments

We thank Dr. Azuko Iwane for generously providing us with the BDTC chicken gizzard RLC construct. This work was supported by the United Kingdom Medical Research Council and the Wellcome Trust.

Acknowledgments

Notes

Abbreviations: AM, actomyosin; S1, subfragment 1; M.ADP, myosin-ADP; M.PPi, myosin-pyrophosphate; AMPPNP, adenyl-5′yl imidodiphosphate; M.AMPPNP, myosin-AMPPNP; RLC, regulatory light chain; BDTC, biotin-dependent transcarboxylase; QD, quadrant detector.

Notes
Abbreviations: AM, actomyosin; S1, subfragment 1; M.ADP, myosin-ADP; M.PPi, myosin-pyrophosphate; AMPPNP, adenyl-5′yl imidodiphosphate; M.AMPPNP, myosin-AMPPNP; RLC, regulatory light chain; BDTC, biotin-dependent transcarboxylase; QD, quadrant detector.

References

  • 1. Reedy, M. K., Holmes, K. C. & Tregear, R. T. (1965) Nature207, 1276–1280. [[PubMed]
  • 2. Huxley, H. E. (1969) Science164, 1356–1366. [[PubMed]
  • 3. Lymn, R. W. & Taylor, E. W. (1971) Biochemistry10, 4617–4624. [[PubMed]
  • 4. Eisenberg, E. & Hill, T. L. (1985) Science227, 999–1006. [[PubMed]
  • 5. Goody, R. S., Hofmann, W. & Mannherz, G. H. (1977) Eur. J. Biochem.78, 317–324. [[PubMed]
  • 6. Marston, S. & Weber, A. (1975) Biochemistry14, 3868–3873. [[PubMed]
  • 7. White, H. D. & Taylor, E. W. (1976) Biochemistry15, 5818–5826. [[PubMed]
  • 8. Geeves, M. A., Goody, R. S. & Gutfreund, H. (1984) J. Muscle Res. Cell Motil.5, 351–361. [[PubMed]
  • 9. Geeves, M. A. & Holmes, K. C. (1999) Annu. Rev. Biochem.68, 687–728. [[PubMed]
  • 10. Finer, J. T., Simmons, R. M. & Spudich, J. A. (1994) Nature368, 113–119. [[PubMed]
  • 11. Iwane, A. H., Kitamura, K., Tokunaga, M. & Yanagida, T. (1997) Biochem. Biophys. Res. Commun.230, 76–80. [[PubMed]
  • 12. Trybus, K. M. & Chatman, T. A. (1993) J. Biol. Chem.268, 4412–4419. [[PubMed]
  • 13. Ishijima, A., Kojima, H., Funatsu, T., Tokunaga, M., Higuchi, H., Tanaka, H. & Yanagida, T. (1998) Cell92, 161–171. [[PubMed]
  • 14. Steffen, W., Smith, D., Simmons, R. & Sleep, J. (2001) Proc. Natl. Acad. Sci. USA98, 14949–14954.
  • 15. Smith, D. A., Steffen, W., Simmons, R. M. & Sleep, J. (2001) Biophys. J.81, 2795–2816.
  • 16. Molloy, J. E., Burns, J. E., Kendrick-Jones, J., Tregear, R. T. & White, D. C. (1995) Nature378, 209–212. [[PubMed]
  • 17. Taylor, E. W. (1991) J. Biol. Chem.266, 294–302. [[PubMed]
  • 18. Trybus, K. M. & Taylor, E. W. (1982) Biochemistry21, 1284–1294. [[PubMed]
  • 19. Jontes, J. D., Wilson-Kubalek, E. M. & Milligan, R. A. (1995) Nature378, 751–753. [[PubMed]
  • 20. Dantzig, J. A., Hibberd, M. G., Trentham, D. R. & Goldman, Y. E. (1991) J. Physiol. (London)432, 639–680.
  • 21. Geeves, M. A. (1989) Biochemistry28, 5864–5871. [[PubMed]
  • 22. Sleep, J. A. & Hutton, R. L. (1980) Biochemistry19, 1276–1283. [[PubMed]
  • 23. Dantzig, J. A., Goldman, Y. E., Millar, N. C., Lacktis, J. & Homsher, E. (1992) J. Physiol. (London)451, 247–278.
  • 24. Urbanke, C. & Wray, J. (2001) Biochem. J.358, 165–173.
  • 25. Malnasi-Csizmadia, A., Woolley, R. J. & Bagshaw, C. R. (2000) Biochemistry39, 16135–16146. [[PubMed]
  • 26. Malnasi-Csizmadia, A., Pearson, D. S., Kovacs, M., Woolley, R. J., Geeves, M. A. & Bagshaw, C. R. (2001) Biochemistry40, 12727–12737. [[PubMed]
  • 27. Xu, S., Offer, G., Gu, J., White, H. D. & Yu, L. C. (2003) Biochemistry42, 390–401. [[PubMed]
  • 28. Kuhn, H. J. (1981) J. Muscle Res. Cell Motil.2, 7–44. [[PubMed]
  • 29. Schmitz, H., Reedy, M. C., Reedy, M. K., Tregear, R. T., Winkler, H. & Taylor, K. A. (1996) J. Mol. Biol.264, 279–301. [[PubMed]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.